Morphogenesis and the response to injury by tissues both involve communication between cells and their microenvironment. The microenvironment is composed of soluble signals such as growth factors, and insoluble signals such as the extracellular matrix. These signals impart instructional information to cells through receptors that control pattern formation and the acquisition of specialized cell functions. The syndecan family of cell surface heparan sulfate proteoglycans bind to and mediate the action of several of these growth factors and extracellular matrix components. Thus, by changing the expression of syndecans, cells control their responsiveness to the microenvironment. Our prior work has shown that expression of two syndecan family members can be controlled by synducin, a unique protein that is released during wound repair. Our central hypothesis is that control of syndecan expression at the cell surface regulates cellular behaviors involved in morphogenesis and wound repair. Synducin, as an inducer of syndecans, can therefore influence cellular behaviors by control of syndecan expression. Synducin may also have other biological effects. This proposal seeks to change the normal expression of synducin in mice by a transgenic approach. This approach will evaluate the biological effects of synducin in vivo and may give insight into the significance of altered syndecan expression during injury and embryogenesis. Thus, our Specific Aims ar to: (i) Evaluate the functional consequences of over-expression of synducin in transgenic mice. (ii) Evaluate the functional consequences of tissue-specific overexpression of synducin in the skin of transgenic mice. (iii) Determine the genomic structure of synducin. (iv) Evaluate the functional consequences of targeted deletion of synducin.

Project Start
Project End
Budget Start
Budget End
Support Year
2
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Brigham and Women's Hospital
Department
Type
DUNS #
071723621
City
Boston
State
MA
Country
United States
Zip Code
02115
Tian, Tian; Jin, Michelle Qiushuang; Dubin, Krista et al. (2017) IL-1R Type 1-Deficient Mice Demonstrate an Impaired Host Immune Response against Cutaneous Vaccinia Virus Infection. J Immunol 198:4341-4351
Pan, Youdong; Tian, Tian; Park, Chang Ook et al. (2017) Survival of tissue-resident memory T cells requires exogenous lipid uptake and metabolism. Nature 543:252-256
Volpicelli, Elgida R; Lezcano, Cecilia; Zhan, Qian et al. (2014) The multidrug-resistance transporter ABCB5 is expressed in human placenta. Int J Gynecol Pathol 33:45-51
Guenova, Emmanuella; Watanabe, Rei; Teague, Jessica E et al. (2013) TH2 cytokines from malignant cells suppress TH1 responses and enforce a global TH2 bias in leukemic cutaneous T-cell lymphoma. Clin Cancer Res 19:3755-63
Majewska-Szczepanik, Monika; Paust, Silke; von Andrian, Ulrich H et al. (2013) Natural killer cell-mediated contact sensitivity develops rapidly and depends on interferon-?, interferon-? and interleukin-12. Immunology 140:98-110
Zadran, Sohila; McMickle, Robert; Shackelford, David et al. (2013) Monitoring extra-vascular migratory metastasis (EVMM) of migrating cancer cells using an in vitro co-culture system. Protoc exch 2013:
Burkhardt, Ute E; Hainz, Ursula; Stevenson, Kristen et al. (2013) Autologous CLL cell vaccination early after transplant induces leukemia-specific T cells. J Clin Invest 123:3756-65
Dowlatshahi, Mitra; Huang, Victor; Gehad, Ahmed E et al. (2013) Tumor-specific T cells in human Merkel cell carcinomas: a possible role for Tregs and T-cell exhaustion in reducing T-cell responses. J Invest Dermatol 133:1879-89
Seneschal, Julien; Clark, Rachael A; Gehad, Ahmed et al. (2012) Human epidermal Langerhans cells maintain immune homeostasis in skin by activating skin resident regulatory T cells. Immunity 36:873-84
Girouard, Sasha D; Laga, Alvaro C; Mihm, Martin C et al. (2012) SOX2 contributes to melanoma cell invasion. Lab Invest 92:362-70

Showing the most recent 10 out of 113 publications